IL162920A0 - Selective enzymatic esterification and solvolysis of epimeric vitamin d analog and separation of theepimers - Google Patents

Selective enzymatic esterification and solvolysis of epimeric vitamin d analog and separation of theepimers

Info

Publication number
IL162920A0
IL162920A0 IL16292003A IL16292003A IL162920A0 IL 162920 A0 IL162920 A0 IL 162920A0 IL 16292003 A IL16292003 A IL 16292003A IL 16292003 A IL16292003 A IL 16292003A IL 162920 A0 IL162920 A0 IL 162920A0
Authority
IL
Israel
Prior art keywords
analog
theepimers
solvolysis
separation
enzymatic esterification
Prior art date
Application number
IL16292003A
Other languages
English (en)
Original Assignee
Va Pharmaceutical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Va Pharmaceutical Ind Ltd filed Critical Va Pharmaceutical Ind Ltd
Publication of IL162920A0 publication Critical patent/IL162920A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/62Carboxylic acid esters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/18Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic polyhydric
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL16292003A 2002-01-10 2003-01-09 Selective enzymatic esterification and solvolysis of epimeric vitamin d analog and separation of theepimers IL162920A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34808202P 2002-01-10 2002-01-10
US34997702P 2002-01-18 2002-01-18
PCT/US2003/000623 WO2003060094A2 (en) 2002-01-10 2003-01-09 Selective enzymatic esterification and solvolysis of epimeric vitamin d analog and separation of the epimers

Publications (1)

Publication Number Publication Date
IL162920A0 true IL162920A0 (en) 2005-11-20

Family

ID=26995556

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16292003A IL162920A0 (en) 2002-01-10 2003-01-09 Selective enzymatic esterification and solvolysis of epimeric vitamin d analog and separation of theepimers

Country Status (15)

Country Link
US (1) US8129173B2 (ja)
EP (1) EP1470220B1 (ja)
JP (1) JP2005514929A (ja)
KR (1) KR100630859B1 (ja)
CN (1) CN1639329A (ja)
AT (1) ATE527372T1 (ja)
AU (1) AU2003210473A1 (ja)
CA (1) CA2472178A1 (ja)
HR (1) HRP20040674A2 (ja)
IL (1) IL162920A0 (ja)
IS (1) IS7347A (ja)
MX (1) MXPA04006741A (ja)
NO (1) NO20043323L (ja)
PL (1) PL373677A1 (ja)
WO (1) WO2003060094A2 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
WO2003106412A1 (en) 2002-06-13 2003-12-24 Teva Pharmaceutical Industries Ltd. Epimerization of analogs of vitamin d
EP1458678A1 (en) * 2002-11-18 2004-09-22 Teva Pharmaceutical Industries Limited A crystallization method for purification of calcipotriene
US8362287B2 (en) 2004-03-18 2013-01-29 Leo Pharma A/S Stereoselective synthesis of vitamin D analogues
PL207034B1 (pl) 2004-12-30 2010-10-29 Inst Farmaceutyczny Sposób wytwarzania bezwodnego kalcypotriolu
EP2526930B1 (en) * 2005-06-01 2013-12-25 GlaxoSmithKline Intellectual Property Development Limited Vitamin formulation
TW200643172A (en) * 2005-06-01 2006-12-16 Formosa Lab Inc Selective enzymatic esterfication and solvolysis of epimeric vitamin D analog and separation and epimerization of the epimers
CN100404686C (zh) * 2005-06-10 2008-07-23 台耀化学股份有限公司 维生素d衍生物异构物的分离及异构化的方法
CN101906443B (zh) * 2010-06-25 2012-07-25 绍兴文理学院 (2S)-[2-(t-叔丁基)二甲基硅氧基]-2-环丙基-1-乙基-三苯基膦的合成方法
US9119528B2 (en) 2012-10-30 2015-09-01 Dexcom, Inc. Systems and methods for providing sensitive and specific alarms
CN103694156B (zh) * 2014-01-07 2015-09-02 成都医路康医学技术服务有限公司 一种银屑病治疗药物钙泊三醇的制备方法
CN104830943B (zh) * 2015-03-18 2019-03-01 上海皓元生物医药科技有限公司 一种艾尔骨化醇中间体的制备方法
CN106188122B (zh) * 2015-05-05 2019-05-14 上海医药工业研究院 一种手性烯丙醇类化合物的差向异构化方法
CN115418389A (zh) * 2019-03-19 2022-12-02 美国西门子医学诊断股份有限公司 减轻疏水分析物的体外诊断测定中的脂蛋白干扰的组合物、装置和方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4594340A (en) 1984-11-29 1986-06-10 Hoffmann-La Roche Inc. 25,26-dehydro-1α,24R-dihydroxycholecalciferol and 25,26-dehydro-1α,24S-dihydroxycholecalciferol and the epimeric mixture
US4866048A (en) * 1985-08-02 1989-09-12 Leo Pharmaceutical Products Ltd. Novel vitamin D analogues
DE3743824C2 (de) * 1987-12-23 1997-03-06 Hoechst Ag Verfahren zur enzymatischen Racematspaltung von racemischen Alkoholen mit/in Vinylestern durch Umesterung
US4996158A (en) * 1987-12-26 1991-02-26 Junichi Oda Optical resolution of racemic alcohols
US5401731A (en) 1989-06-29 1995-03-28 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Productionsaktieselskab) Vitamin D analogues
DE3933034A1 (de) 1989-10-02 1991-04-11 Schering Ag 24-homo-vitamin-d-derivate, verfahren zu ihrer herstellung
ATE145942T1 (de) * 1990-08-13 1996-12-15 Suntory Ltd Verfahren zur herstellung optisch aktiver alpha- hydroxyalkenderivate
EP0550702B1 (en) 1991-01-08 1999-05-06 Bone Care International, Inc. METHODS FOR PREPARATION AND USE OF 1$g(a),24-DIHYDROXY VITAMIN D 2?
US5789397A (en) 1991-01-08 1998-08-04 Bone Care International, Inc. Methods for preparation and use of 1A,24(S)-dihydroxy vitamin D2
US5413935A (en) * 1991-04-24 1995-05-09 E. R. Squibb & Sons, Inc. Process for selecting an enantiomer of a hydroxy lactone using pseudomonas lipase
US6262283B1 (en) 1996-12-06 2001-07-17 Magainin Pharmaceuticals Inc. Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
JPH11130711A (ja) 1997-10-24 1999-05-18 Teijin Ltd 1α,24,25−トリヒドロキシビタミンD3類の合成中間体およびその製造法
JP2002508383A (ja) 1997-12-17 2002-03-19 シエーリング アクチエンゲゼルシャフト 側鎖中にリン原子を有するビタミンd誘導体
GB9908327D0 (en) * 1999-04-12 1999-06-09 Chirotech Technology Ltd Process for the preparation of prostaglandin precursors
US6362350B1 (en) 1999-07-01 2002-03-26 Wisconsin Alumni Research Foundation Crystalline 1α, 24(S)-dihydroxyvitamin D2 and method of purification thereof
JP2001204484A (ja) 2000-01-20 2001-07-31 Eisai Co Ltd 酵素を用いる光学活性体の製造法
NL1015313C2 (nl) * 2000-05-26 2001-11-27 Dsm Nv Werkwijze voor de bereiding van enantiomeer verrijkte esters en alcoholen.
WO2003106412A1 (en) * 2002-06-13 2003-12-24 Teva Pharmaceutical Industries Ltd. Epimerization of analogs of vitamin d

Also Published As

Publication number Publication date
US20030166226A1 (en) 2003-09-04
NO20043323L (no) 2004-08-10
EP1470220B1 (en) 2011-10-05
JP2005514929A (ja) 2005-05-26
AU2003210473A1 (en) 2003-07-30
MXPA04006741A (es) 2006-05-31
US8129173B2 (en) 2012-03-06
KR20040081122A (ko) 2004-09-20
PL373677A1 (en) 2005-09-05
CA2472178A1 (en) 2003-07-24
EP1470220A2 (en) 2004-10-27
ATE527372T1 (de) 2011-10-15
KR100630859B1 (ko) 2006-10-04
WO2003060094A3 (en) 2003-12-24
WO2003060094A2 (en) 2003-07-24
HRP20040674A2 (en) 2005-06-30
CN1639329A (zh) 2005-07-13
EP1470220A4 (en) 2007-12-05
IS7347A (is) 2004-07-07

Similar Documents

Publication Publication Date Title
IL162920A0 (en) Selective enzymatic esterification and solvolysis of epimeric vitamin d analog and separation of theepimers
AU1422597A (en) Methods for the selective separation of organic components from biological fluids
ATE305296T1 (de) Zusammensetzungen und verfahren zur behandlung von abnormaler zellvermehrung
SG131760A1 (en) Improved process for methacrylic acid and methacrylic acid ester production
BR9811781B1 (pt) processo para separação de ácido acrìlico ou de ácido metacrìlico a partir de uma mistura gasosa.
CA2192348A1 (en) Delayed acid for gel breaking
MY128271A (en) Purification method for (meth) acrylic acid
AU5453496A (en) Process for the desulfurization of sulfurous acid gas-containing waste gas
BR9607640A (pt) Processo para remover impurezas de argilas de caulim
PT1789445E (pt) Processo para a extracção de fibronectina a partir de fracções de plasma
AU2002363345A1 (en) Method for the production of fuel from acid fats and system for carrying out said method
AU7375794A (en) Process for isolating nucleic acid from gram positive microorganisms
AU2003283391A1 (en) Voice processing system, method for allocating acoustic and/or written character strings to words or lexical entries
EP1520003B8 (en) Process for recovery of plant sterols from by-product of vegetable oil refining
AU3650495A (en) Process for the purification of 2,6-diisopropylphenol
IS6034A (is) Aðferð til að einangra Pseudomonas sýru A úr ræktunarseyði sem inniheldur Pseudomonas sýrukomplex
AU2003258667A1 (en) Method for the production by fermentation of sulphur-containing fine chemicals (metf)
ATE470657T1 (de) Verfahren zur herstellung von isocyanaten
AU3763797A (en) Process for the removal of mercury from smelter gases
HRP20050415B1 (en) A process for the purification of 1,4-butanediol mononitrate
WO2003042236A1 (fr) Procede de fabrication de proteines concentrees/epurees a l'aide d'une composition minerale d'argile
BR0207877A (pt) Método para remoção de cálcio de uma solução de sulfato em um processo de produção de zinco
AU2001295460A1 (en) Method for producing an air separation installation
HRP20030356A2 (en) Process for enzymatic production of enantiomer-enriched -amino acids
ZA976854B (en) Treatment of psychotic disorders.

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees